Clinical trial
Efficacy and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03804931 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis
- Lead sponsor
- Guangzhou First People's Hospital
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- January 20, 2019
- Completion date
- December 31, 2030
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fecal microbiota transplantation, ulcerative colitis